People · Operator
Named in public records as an officer, director or promoter · active 2017–2018 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alitair Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $6.1M | $3.6M | 2017 |
Robert E. Casale at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert E. Casale on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William W Howard | 1 | 1 |
| Frank E. Guarino | 1 | 1 |
| James E. Hoyes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.